NewsAugust 23, 2019GW confident epilepsy drug will get NHS funding despite NICE rejection Share XGW confident epilepsy drug will get NHS funding despite NICE rejectionhttps://pharmaphorum.com/news/no-repeat-of/
NewsJuly 31, 2019Cancer update buoys Amgen despite Q2 sales fall Share XCancer update buoys Amgen despite Q2 sales fallhttps://pharmaphorum.com/news/cancer-update-buoys-amgen-despite-q2-sales-fall/
NewsJuly 30, 2019Study resurrects Merck’s hopes for Keytruda in breast cancer Share XStudy resurrects Merck’s hopes for Keytruda in breast cancerhttps://pharmaphorum.com/news/study-resurrects-mercks-hopes-for-keytruda-in-breast-cancer/
NewsJuly 24, 2019EMA starts review of Xtandi in hormone-sensitive prostate cancer Share XEMA starts review of Xtandi in hormone-sensitive prostate cancerhttps://pharmaphorum.com/news/ema-starts-review-of-xtandi-in-hormone-sensitive-prostate-cancer/
NewsJuly 2, 2019Immediately after EU nod, England’s NHS funds Sanofi skin cancer drug Share XImmediately after EU nod, England’s NHS funds Sanofi skin cancer drughttps://pharmaphorum.com/news/immediately-after-eu-nod-englands-nhs-funds-sanofi-skin-cancer-drug/
NewsJuly 1, 2019Roche closes on EU approval for Tecentriq in breast cancer Share XRoche closes on EU approval for Tecentriq in breast cancerhttps://pharmaphorum.com/news/roche-closes-on-eu-approval-for-tecentriq-in-breast-cancer/
NewsJuly 1, 2019AZ’s asthma and diabetes drugs get label boosts in EU Share XAZ’s asthma and diabetes drugs get label boosts in EUhttps://pharmaphorum.com/news/azs-asthma-and-diabetes-drugs-get-label-boosts-in-eu/
NewsJuly 1, 2019CHMP says no to Amgen’s osteoporosis drug Evenity Share XCHMP says no to Amgen’s osteoporosis drug Evenityhttps://pharmaphorum.com/news/chmp-says-no-to-amgens-osteoporosis-drug-evenity/
NewsJune 4, 2019bluebird claims first approval for gene therapy Zynteglo in EU Share Xbluebird claims first approval for gene therapy Zynteglo in EUhttps://pharmaphorum.com/news/bluebird-claims-first-approval-for-gene-therapy-zynteglo-in-eu/
NewsMay 31, 2019Mitsubishi Tanabe pulls ALS drug from EMA assessment Share XMitsubishi Tanabe pulls ALS drug from EMA assessmenthttps://pharmaphorum.com/news/mitsubishi-tanabe-pulls-als-drug-from-ema-assessment/
NewsMay 20, 2019EU regulators slap safety restriction on Pfizer’s Xeljanz Share XEU regulators slap safety restriction on Pfizer’s Xeljanzhttps://pharmaphorum.com/news/eu-regulators-slap-safety-restriction-on-pfizers-xeljanz/
NewsMay 8, 2019Ionis’ FCS drug approved in EU, launch due in Germany Share XIonis’ FCS drug approved in EU, launch due in Germanyhttps://pharmaphorum.com/news/ionis-fcs-drug-approved-in-eu-launch-due-in-germany/
